I was first exposed to the idea of microdosing psychedelics after listening to some interviews with Dr. James Fadiman. Dr. Fadiman is the author of The Psychedelic Explorer’s guide. After hearing him speak about it I immediately knew I had to try it. Microdosing is ingesting a small amount of a psychedelic substance. The dosages are between 0.2 and 0.4 grams of psilocybin, 6-25 micrograms of lsd or 50-75 micrograms of mescaline. The effects aren’t the typical effects of a psychedelic trip. The effects and benefits are as follows
1) Energy Boost- Microdosing gave me an amazing boost in energy and alertness. I felt it for an extended period of time, about 6-8 hours, without any jitters or anxiety. This is my favorite part as I have experimented with nootropics and other substances to try to get this boost.
2) Mental Clarity- I experienced a very clear mental state. My thoughts were fluid and came to me with ease. I wasn’t made anxious or nervous by racing thoughts. This resulted in a very patient and relaxed feeling. The reason I enjoyed the microdosing experience so much is that this usually doesn’t happen when you take stimulants like caffeine or anything that gives you and energy boost. The relaxed feeling and mental clarity combined with the energy boost led to me being very productive.
3) Slightly Enhanced Vision- At high doses of psychedelics users usually report that colors are brighter or sharper. I felt that I experienced this at a lesser degree.
4) Compassion and Gratitude- While microdosing I seemed to be more in tune with a sense of compassion and gratitude. I didn’t have to quell any anger when cut off in traffic and I remember feeling very grateful for the beautiful weather.
While I do not encourage everyone to go try this now I do have to say I think many could benefit from the occasional microdose of a psychedelic substance. It seems obvious to me also that more research has to be done because there seems to be a potential treatment available for things like depression and anxiety in these substances.
Hello everyone and thank you for visiting my website. The goal of this site is to be a resource for fellow psychonauts who enjoy exploring altered states and blurring the boundaries of reality. By living a psychedelic life we challenge our previous notions of life and the world around us. Exploring our own consciousness and altered states we can break through boundaries and fears and live a truly meaningful life. I hope you enjoy my content and if you have any suggestions, comments, or questions you can reach me at email@example.com.
How important are psychedelics in the religious experience of the United States? We know drugs like LSD and psilocybin can occasion powerful, life-changing experiences of awe and renewal. We also know psychedelics have been used by millions of people since the 1960s. But no one has ever tried to count the number of people who’ve had psychedelic-related mystical experiences. I ran a survey of over 6,000 people to get an answer. Background: Walter ‘Wally’ Pahnke and psychedelic mysticism Fifty-one years ago, a massive 9.2 Richter scale earthquake shook Alaska. At the same time, Wally Pahnke was experiencing another sort of earthquake. It was Good Friday and the Harvard graduate was having his first experience with a high dose of an experimental drug called LSD. As the drug took effect Pahnke first became aware of his core self — not the usual self that worried about the opinions of others or what-to-eat — but a “core stripped bare of all pretense and falseness,” as he described in a letter. Then Pahnke went somewhere else. There was a white light of absolute purity and cleanness, like a glowing and sparkling flame, so penetrating and intense that it was not possible to look directly at it. Awe, […]Read More
Even the hardiest, most vocal psychedelic enthusiasts recognize that trip experiences can be intense and sometimes difficult. Especially when taken in unfamiliar surroundings — such as crowded music festivals or in the desert heat of Black Rock City — psychedelics can cause untimely emotional meltdowns. Now there’s an excellent guide for handling psychedelic crises, produced by some of foremost experts on harm reduction techniques. It’s called “The Manual of Psychedelic Support,” and its laundry list of contributors includes the Erowids, Rick Doblin, Jon Hanna (the founder of Mind States), Linnae Ponté (who runs MAPS’ excellent Zendo harm reduction tent), five members of Kosmicare UK, Dave King (co-director of Breaking Convention), and too many more to list. Featured artists include Alex and Allyson Grey, Fred Tomaselli, Luke Brown, Robert Venosa, and more. This free guide is full of insight, and not just for festival organizers. Anyone who uses psychedelics will find immense value in this sleekly-designed manual. Whether you’re hosting a big party or just dropping acid with an old friend, it’s wise to prepare for any unpleasant surprises. Anything that fine-tunes your sense of compassion is a good thing, right? From the website, PsychSitter.com: The Manual of Psychedelic Support is a comprehensive guide to setting up and running compassionate […]
The post Fantastic New Trip-Sitting Guide: The Manual of Psychedelic Support appeared first on Psychedelic Frontier.Read More
Dr. David Nutt and Dr. Robin Carhart-Harris, the researchers who blew your mind with a landmark psilocybin study in 2013, are at it again. This time they’re examining the effects of LSD on the brain, and they want your help. The active research phase has already been conducted — 20 volunteers were dosed and scanned, producing the world’s first images of brains on LSD. Now the researchers must analyze the raw data before they can publish the results. To fund this final phase of the study, the scientists have launched a crowd-funding campaign on Walacea.com in partnership with the Beckley Foundation. Within the first 24 hours, they were overwhelmed with donations, handily surpassing their original funding goal of £25,000 (about $37,600). In fact, with 40 days to go, they’ve already raised over £40,000. Why crowd-funding? The scientists explain: It is difficult to find funding for psychedelic research as the subject is surrounded by taboo, but we hope that there are many of you who will be excited to provide funding so that this fascinating and important research project can be completed. Watch the crowd-funding video for a sneak peek into this cutting-edge research: The team’s previous psychedelic research Dr. Nutt and Dr. Carhart-Harris are responsible for the 2013 study that upended […]
The post Scientists are crowd-funding the first ever LSD brain imaging study appeared first on Psychedelic Frontier.Read More
Today’s post is by Paul Hayes, Hon. Professor Drug Policy at London School of Hygiene & Tropical Medicine. It was originally published on The Conversation. Drug use is common, drug addiction is rare. About one adult in three will use an illegal drug in their lifetime and just under 3m people will do so this year in England and Wales alone. Most will suffer no long-term harm. There are immediate risks from overdose and intoxication, and longer-term health risks associated with heavy or prolonged use; damage to lungs from smoking cannabis or the bladder from ketamine for example. However most people will either pass unscathed through a short period of experimentation or learn to accommodate their drug use into their lifestyle, adjusting patterns of use to their social and domestic circumstances, as they do with alcohol. Compared to the 3m currently using illegal drugs there are around 300,000 heroin and/or crack addicts while around 30,000 were successfully treated for dependency on drugs in England in 2011-12, typically cannabis, or powder cocaine. A powerful cultural narrative focusing on the power of illegal drugs to disrupt otherwise stable, happy lives dominates our media and political discourse, and shapes policy responses. Drug use is […]
The post Many people use drugs – but here’s why most don’t become addicts appeared first on Psychedelic Frontier.Read More
David Presti celebrates Sasha Shulgin in the most recent MAPS Bulletin. Alexander “Sasha” Shulgin was born in Berkeley on June 17, 1925, and received his bachelor’s (1949) and doctorate (1955) degrees from the local college, the University of California in Berkeley. Except for some time spent as an undergraduate at Harvard and a stint in the U.S. Navy during World War II, he lived his entire life either in Berkeley or nearby in the East Bay. Sasha’s doctoral research in biochemistry at UC Berkeley developed methods for the synthesis of amino acids containing chemical isotopes of carbon and nitrogen. Isotopically labeled molecules like these are useful for investigating details of metabolic pathways, how the body manufactures this from that. Although Sasha later wrote that his doctoral work was “uninspired” and “dull” (PiHKAL, Chapter 2), adjectives like these are commonly applied to graduate-school projects. The primary goal of doctoral research in science is generally not to accomplish one’s best and most creative work, but to muck around and build intuition in the subject area. No doubt Sasha’s intuitions about molecular structure and chemical syntheses grew immensely during this period, and he was set on his way to becoming the artistic genius of […]
The post Too Big for a Nobel Prize: Remembering Sasha Shulgin appeared first on Psychedelic Frontier.Read More
This interview originally appeared in the MAPS Bulletin Winter 2014 Vol. 24, No. 3 – Annual Report. Featuring Annie Mithoefer, B.S.N., Shannon Clare Petitt, I.M.F., Saj Razvi, L.P.C., Ben Shechet, and Will Van Derveer, M.D, it sheds a great deal of light on MDMA-assisted therapy and the people behind MAPS. Annie Mithoefer, B.S.N., is a co-investigator for MAPS’ study of MDMA-assisted psychotherapy for service-related PTSD in U.S. veterans, police officers, and firefighters in Charleston, SC. She is also a Registered Nurse, Grof-certified Holotropic Breathwork Practitioner and is trained in Hakomi Therapy and can be reached at firstname.lastname@example.org. Shannon Clare Petitt, I.M.F., is a co-therapist for MAPS’ study of MDMA-assisted psychotherapy for anxiety associated with a life-threatening illness. Her clinical work has been with individuals and groups, of all ages, experiencing trauma, addiction, depression, and dual-diagnosis. She can be reached at email@example.com. Saj Razvi, L.P.C., is a clinical researcher in MAPS’ study of MDMA-assisted psychotherapy for PTSD in Boulder, CO. He is Executive Director of the Trauma Recovery Institute in Denver, CO, and runs the trauma education program at the Univ. of Colorado Hospital’s CeDAR addiction treatment center. He can be reached at firstname.lastname@example.org. Ben Shechet is a Clinical Research Associate at MAPS. […]
The post A Conversation with MDMA-Assisted Psychotherapy Researchers appeared first on Psychedelic Frontier.Read More
25 February 2015 — This article has been updated to better reflect the limitations of the study. A new species of lichen has been discovered in the Ecuadorian Amazon rainforest, according to a recent paper published in The Bryologist. Researchers led by lead author Michaela Schmull have tentatively identified tryptamine and psilocybin in the lichen, among other potential substances. The story is a rather unusual one. There is only one known sample of the lichen in all of Western science, and it was collected in 1981 by ethnobotanists Wade Davis and Jim Yost while conducting research in Ecuador. In a 1983 paper describing their discovery of this lichen, Davis and Yost write: In the spring of 1981, whilst we were engaged in ethnobotanical studies in eastern Ecuador, our attention was drawn to a most peculiar use of hallucinogens by the Waorani, a small isolated group of some 600 Indians. … Amongst most Amazonian tribes, hallucinogenic intoxication is considered to be a collective journey into the subconscious and, as such, is a quintessentially social event. … The Waorani, however, consider the use of hallucinogens to be an aggressive anti-social act; so the shaman, or ido, who desires to project a curse takes the drug alone […]
The post New species of lichen is apparently psychedelic: Dictyonema huaorani appeared first on Psychedelic Frontier.Read More